Market research
FTT.AU Factor Therapeutics Limited
AU AUD Healthcare
Latest close
—
—
Loading market data…
Test a moving-average rule with historical data.
Market facts
- Market cap
- 521K
- P/E ratio
- Not available
- Analyst target
- 0.01
- Dividend yield
- 0.0%
- Beta
- 0.42
Community
Investor discussion
1 comment
Sign in to join the FTT.AU discussion.
5 years, 5 months ago
Factor Therapeutics Limited is currently in a long term uptrend where the price is trading 0.0% above its 200 day moving average.
From a valuation standpoint, the stock is 100.0% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 0.0.
Factor Therapeutics Limited's total revenue rose by 119.9% to $4K since the same quarter in the previous year.
Its net income has increased by 3.3% to $-345K since the same quarter in the previous year.
Finally, its free cash flow fell by 576.7% to $-125K since the same quarter in the previous year.
Based on the above factors, Factor Therapeutics Limited gets an overall score of 4/5.